1091 related articles for article (PubMed ID: 26581499)
21. Purinergic signaling in retinal degeneration and regeneration.
Reichenbach A; Bringmann A
Neuropharmacology; 2016 May; 104():194-211. PubMed ID: 25998275
[TBL] [Abstract][Full Text] [Related]
22. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.
Pedata F; Corsi C; Melani A; Bordoni F; Latini S
Ann N Y Acad Sci; 2001 Jun; 939():74-84. PubMed ID: 11462806
[TBL] [Abstract][Full Text] [Related]
23. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
[TBL] [Abstract][Full Text] [Related]
24. Purinoceptors in the nervous system.
Fredholm BB
Pharmacol Toxicol; 1995 Apr; 76(4):228-39. PubMed ID: 7617551
[TBL] [Abstract][Full Text] [Related]
25. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
Chiarella AM; Ryu YK; Manji GA; Rustgi AK
Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
[TBL] [Abstract][Full Text] [Related]
26. Purinergic receptor activation inhibits mitogen-stimulated proliferation in primary neurospheres from the adult mouse subventricular zone.
Stafford MR; Bartlett PF; Adams DJ
Mol Cell Neurosci; 2007 Aug; 35(4):535-48. PubMed ID: 17553694
[TBL] [Abstract][Full Text] [Related]
27. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.
Zhang X; Zhang M; Laties AM; Mitchell CH
J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847
[TBL] [Abstract][Full Text] [Related]
28. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
29. Activation of adenosine and P2Y receptors by ATP in human peripheral nerve.
Lang PM; Tracey DJ; Irnich D; Sippel W; Grafe P
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):449-57. PubMed ID: 12382074
[TBL] [Abstract][Full Text] [Related]
30. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
31. Reactive oxygen species contribute to the promotion of the ATP-mediated proliferation of mouse skeletal myoblasts.
Sciancalepore M; Luin E; Parato G; Ren E; Giniatullin R; Fabbretti E; Lorenzon P
Free Radic Biol Med; 2012 Oct; 53(7):1392-8. PubMed ID: 22917975
[TBL] [Abstract][Full Text] [Related]
32. GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.
Saransaari P; Oja SS
Neurochem Res; 2005 Apr; 30(4):467-73. PubMed ID: 16076017
[TBL] [Abstract][Full Text] [Related]
33. Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.
Schneider G; Glaser T; Lameu C; Abdelbaset-Ismail A; Sellers ZP; Moniuszko M; Ulrich H; Ratajczak MZ
Mol Cancer; 2015 Nov; 14():201. PubMed ID: 26597723
[TBL] [Abstract][Full Text] [Related]
34. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
35. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release.
Rayment SJ; Ralevic V; Barrett DA; Cordell R; Alexander SP
FASEB J; 2007 Feb; 21(2):577-85. PubMed ID: 17167068
[TBL] [Abstract][Full Text] [Related]
36. Adenosine and ATP receptors in the brain.
Burnstock G; Fredholm BB; Verkhratsky A
Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
[TBL] [Abstract][Full Text] [Related]
37. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
38. [Neuroprotective mechanisms of adenosine action on CNS neurons].
Zalewska-Kaszubska J
Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
[TBL] [Abstract][Full Text] [Related]
39. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
[TBL] [Abstract][Full Text] [Related]
40. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes.
Kucher BM; Neary JT
J Neurochem; 2005 Feb; 92(3):525-35. PubMed ID: 15659223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
